Log in to save to my catalogue

trastuzumab deruxtecan

trastuzumab deruxtecan

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_ISR_A601397035

trastuzumab deruxtecan

About this item

Full title

trastuzumab deruxtecan

Publisher

Public Library of Science

Journal title

PloS one, 2019-10, Vol.14 (10), p.e0222280

Language

English

Formats

Publication information

Publisher

Public Library of Science

More information

Scope and Contents

Contents

[Fam-] trastuzumab deruxtecan (DS-8201a) is a HER2 (ERBB2)-targeting antibody-drug conjugate, composed of a HER2-targeting antibody and a topoisomerase I inhibitor, exatecan derivative, that has antitumor effects in preclinical xenograft models and clinical trials. Recently, [fam-] trastuzumab deruxtecan was reported to enhance antitumor immunity a...

Alternative Titles

Full title

trastuzumab deruxtecan

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_incontextgauss_ISR_A601397035

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_ISR_A601397035

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0222280

How to access this item